In line with this, leukemic CD34+ progenitor cells of patients with advanced phase CML express high levels of PRAME in comparison to the CD34+ cells of healthy individuals [52]. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.